Blog

//Blog

THE POMEGRANATE POTENTIAL

An innovative Israeli supplement for preventing and improving neurodegenerative diseases is here. BY JUDY SIEGEL-ITZKOVI Pomegranates are known to contain powerful antioxidants that fight the oxygen free radicals that cause inflammation, accelerated aging of the tissues, the activation of harmful genes within DNA and an overloaded immune system. Various herbs, spices such as turmeric and [...]

By | 2018-02-21T15:14:49+00:00 February 21st, 2018|Blog|Comments Off on THE POMEGRANATE POTENTIAL

Diagnostics co MeMed awarded $4m US Defense Dept grant

Israeli immune based diagnostics company MeMed announced that it has been awarded a $4 million grant by the US Department of Defense's Congressionally Directed Medical Research Programs (CDMRP). The award will support transition of the Tirat Hacarmel-based company's prototype point-of-care (POC) platform towards a final product, including transfer to manufacturing and implementation of cloud connectivity. The [...]

By | 2018-02-20T17:27:17+00:00 February 20th, 2018|Blog|Comments Off on Diagnostics co MeMed awarded $4m US Defense Dept grant

Israel innovation makes up half of Merck healthcare revenue, top official says

  Kai Beckmann, CEO of Performance Materials at Merck, says 'our collaboration has deep roots' as the German pharma and chemical giant expands Jerusalem lab By SHOSHANNA SOLOMON   Israeli innovation is behind almost half of the healthcare revenues of the 350-year-old German pharmaceutical and chemicals firm Merck, Kai Beckmann, CEO of Performance Materials at [...]

By | 2018-02-21T12:54:45+00:00 February 20th, 2018|Blog|Comments Off on Israel innovation makes up half of Merck healthcare revenue, top official says

ALYNnovation: ‘Impossible’ is not in our vocabulary

  ALYNnovation takes medical innovations developed at the ALYN pediatric rehabilitation hospital out of the hospital so that all children can benefit from them. Although most children on respirators are also paralyzed, they can derive a great deal of benefit from treatment with water. The problem is that their respirator must not become wet. "Our [...]

By | 2018-02-28T16:20:04+00:00 February 20th, 2018|Blog|Comments Off on ALYNnovation: ‘Impossible’ is not in our vocabulary

Faster, More Accurate Cancer Detection Using Nanoparticles, Rutgers-Led Study Finds

Light-emitting nanoprobes can detect cancer early and track the spread of tiny tumors By Todd B. Bates | December 11, 2017 This illustration shows how human breast cancer cells in a mouse model were “chased” with novel rare earth nanoscale probes injected intravenously. When the subject is illuminated, the probes glow in an infrared range [...]

By | 2017-12-26T11:23:11+00:00 December 26th, 2017|Blog|Comments Off on Faster, More Accurate Cancer Detection Using Nanoparticles, Rutgers-Led Study Finds

Jewish New Year fruit may hold seeds of hope for brain disease sufferers

 Israeli neurologist, nanotech expert make pomegranate oil capsules that send antioxidants where they can have the most effect By SHOSHANNA SOLOMON | 18 September 2017, 4:36 pm Pomegranates at the Mahane Yehuda market in Jerusalem on August 25, 2016. (Nati Shohat/Flash90) As Jewish families across the world reach for the pomegranate that they customarily eat on Rosh [...]

By | 2017-12-25T14:30:59+00:00 December 25th, 2017|Blog|Comments Off on Jewish New Year fruit may hold seeds of hope for brain disease sufferers

BiomX Acquires RondinX to Boost Microbiome Discovery and Development Capabilities

Acquisition expands BiomX's pipeline with novel microbial targets for treating liver diseases. In parallel, 8VC, an angel investor in RondinX, to invest in BiomX  NEWS PROVIDED BY | Biomx Ltd | Dec 19, 2017, 07:30 ET NESS ZIONA, Israel, Dec. 19, 2017 /PRNewswire/ -- BiomX Ltd., a microbiome company developing customized phage therapies, today announced the acquisition of RondinX. The acquisition fortifies BiomX's [...]

By | 2017-12-21T13:51:00+00:00 December 21st, 2017|Blog|Comments Off on BiomX Acquires RondinX to Boost Microbiome Discovery and Development Capabilities

Future of the #Cancer #Treatments

Ayala #Pharmaceuticals, Founded by Israel Biotech Fund, aMoon and Harel Insurance, Enters Exclusive Worldwide License Agreement with Bristol-Myers Squibb (BMS) to Develop Cancer #Treatments December 06, 2017 09:30 AM Eastern Standard Time REHOVOT, Israel--(BUSINESS WIRE)--Ayala Pharmaceuticals, a #biopharmaceutical company dedicated to developing targeted #cancer therapies, announced today that they have entered into an exclusive worldwide [...]

By | 2017-12-24T10:20:40+00:00 December 7th, 2017|Blog|Comments Off on Future of the #Cancer #Treatments

UK company wins global #medicine #award for its ground-breaking potential MS #treatment

NOVEMBER 07, 2017 A leading scientist battling to halt the development of Multiple Sclerosis has revealed that clinical human trials will start by 2020, after her company was honoured with a major nano medicine award. Dr Su Metcalfe's regenerative nanomedicine company, LIFNano™, was named Most Promising Nanomedicine Project at the International Nano Medicine Awards in Berlin on Tuesday, [...]

By | 2017-12-06T15:53:01+00:00 December 6th, 2017|Blog|Comments Off on UK company wins global #medicine #award for its ground-breaking potential MS #treatment

Atox Bio closes $30M round as it speeds through late-stage trials

by brittany meiling — on December 4, 2017 09:06 AM EST Israel’s Atox Bio has raised $30 million — the latest in a long line of equity deals — to help push its #immune #modulators through late-stage clinical trials. The company is working on immune modulators for patients with severe infections and tissue injury. The company’s lead drug, called Reltecimod, is [...]

By | 2017-12-05T10:45:24+00:00 December 5th, 2017|Blog|Comments Off on Atox Bio closes $30M round as it speeds through late-stage trials